APA aipamena

Okita, R., Shimizu, K., Nojima, Y., Saisho, S., & Nakata, M. (2021). Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad. Thorac Cancer.

Chicago Style aipamena

Okita, Riki, Katsuhiko Shimizu, Yuji Nojima, Shinsuke Saisho, and Masao Nakata. "Tofacitinib Overcomes an IFNγ‐induced Decrease in NK Cell‐mediated Cytotoxicity Via the Regulation of Immune‐related Molecules in LC‐2/ad." Thorac Cancer 2021.

MLA aipamena

Okita, Riki, et al. "Tofacitinib Overcomes an IFNγ‐induced Decrease in NK Cell‐mediated Cytotoxicity Via the Regulation of Immune‐related Molecules in LC‐2/ad." Thorac Cancer 2021.